|
US5728536A
(en)
|
1993-07-29 |
1998-03-17 |
St. Jude Children's Research Hospital |
Jak kinases and regulation of Cytokine signal transduction
|
|
US6004981A
(en)
|
1996-03-08 |
1999-12-21 |
Berlex Laboratories, Inc. |
Benzamidine derivatives and their use as anti-coagulants
|
|
PT813525E
(pt)
|
1995-03-10 |
2004-02-27 |
Berlex Lab |
Derivados de benzamidina e sua utilizacao como anticoagulantes
|
|
US5691364A
(en)
*
|
1995-03-10 |
1997-11-25 |
Berlex Laboratories, Inc. |
Benzamidine derivatives and their use as anti-coagulants
|
|
US6316635B1
(en)
|
1995-06-07 |
2001-11-13 |
Sugen, Inc. |
2-indolinone derivatives as modulators of protein kinase activity
|
|
JPH11512399A
(ja)
|
1995-09-01 |
1999-10-26 |
シグナル ファーマシューティカルズ，インコーポレイテッド |
ピリミジンカルボキサミドおよび関連化合物ならびに炎症状態を処置するための方法
|
|
US5811428A
(en)
|
1995-12-18 |
1998-09-22 |
Signal Pharmaceuticals, Inc. |
Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions
|
|
US6696448B2
(en)
|
1996-06-05 |
2004-02-24 |
Sugen, Inc. |
3-(piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitors
|
|
CA2264521A1
(en)
|
1996-09-12 |
1998-03-19 |
Schering Aktiengesellschaft |
Benzamidine derivatives substituted by cyclic amino acid or cyclic hydroxy acid derivatives and their use as anti-coagulants
|
|
US6008234A
(en)
|
1996-09-12 |
1999-12-28 |
Berlex Laboratories, Inc. |
Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives and their use as anti-coagulants
|
|
US6004985A
(en)
|
1996-10-09 |
1999-12-21 |
Berlex Laboratories, Inc. |
Thio acid derived monocylic N-heterocyclics as anticoagulants
|
|
US6316429B1
(en)
|
1997-05-07 |
2001-11-13 |
Sugen, Inc. |
Bicyclic protein kinase inhibitors
|
|
US6486185B1
(en)
|
1997-05-07 |
2002-11-26 |
Sugen, Inc. |
3-heteroarylidene-2-indolinone protein kinase inhibitors
|
|
GB9718913D0
(en)
|
1997-09-05 |
1997-11-12 |
Glaxo Group Ltd |
Substituted oxindole derivatives
|
|
US6133305A
(en)
|
1997-09-26 |
2000-10-17 |
Sugen, Inc. |
3-(substituted)-2-indolinones compounds and use thereof as inhibitors of protein kinase activity
|
|
US6686364B2
(en)
|
1997-12-08 |
2004-02-03 |
Berlex Laboratories, Inc. |
Benzamidine derivatives and their use as anti-coagulants
|
|
JP4135318B2
(ja)
|
1997-12-15 |
2008-08-20 |
アステラス製薬株式会社 |
新規なピリミジン−５−カルボキサミド誘導体
|
|
JP2004504259A
(ja)
|
1998-06-30 |
2004-02-12 |
パーカー ヒューズ インスティテュート |
Ｊａｋ−３インヒビターを用いたｃ−ｊｕｎ発現の阻害方法
|
|
US6313129B1
(en)
|
1998-08-21 |
2001-11-06 |
Hughes Institute |
Therapeutic compounds
|
|
US6262088B1
(en)
|
1998-11-19 |
2001-07-17 |
Berlex Laboratories, Inc. |
Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
|
|
US6127376A
(en)
|
1998-12-04 |
2000-10-03 |
Berlex Laboratories, Inc. |
Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants
|
|
GB9828511D0
(en)
|
1998-12-24 |
1999-02-17 |
Zeneca Ltd |
Chemical compounds
|
|
US6841567B1
(en)
|
1999-02-12 |
2005-01-11 |
Cephalon, Inc. |
Cyclic substituted fused pyrrolocarbazoles and isoindolones
|
|
US6624171B1
(en)
|
1999-03-04 |
2003-09-23 |
Smithkline Beecham Corporation |
Substituted aza-oxindole derivatives
|
|
GB9904995D0
(en)
|
1999-03-04 |
1999-04-28 |
Glaxo Group Ltd |
Substituted aza-oxindole derivatives
|
|
US6080747A
(en)
|
1999-03-05 |
2000-06-27 |
Hughes Institute |
JAK-3 inhibitors for treating allergic disorders
|
|
GB9905075D0
(en)
|
1999-03-06 |
1999-04-28 |
Zeneca Ltd |
Chemical compounds
|
|
US7125875B2
(en)
|
1999-04-15 |
2006-10-24 |
Bristol-Myers Squibb Company |
Cyclic protein tyrosine kinase inhibitors
|
|
ATE288420T1
(de)
*
|
1999-06-09 |
2005-02-15 |
Yamanouchi Pharma Co Ltd |
Neuartige heterocyclische carboxamid-derivate
|
|
AU5108000A
(en)
|
1999-06-10 |
2001-01-02 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel nitrogen-contaiing heterocyclic derivatives or salts thereof
|
|
GB9918035D0
(en)
|
1999-07-30 |
1999-09-29 |
Novartis Ag |
Organic compounds
|
|
AU4903201A
(en)
|
1999-11-30 |
2001-07-03 |
Parker Hughes Institute |
Inhibitors of thrombin induced platelet aggregation
|
|
ATE380031T1
(de)
|
1999-12-10 |
2007-12-15 |
Pfizer Prod Inc |
Pyrrolo 2,3-d pyrimidinderivate enthaltende zusammensetzungen
|
|
EP1244672B1
(en)
|
1999-12-21 |
2005-07-20 |
Sugen, Inc. |
4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
|
|
US20020065270A1
(en)
|
1999-12-28 |
2002-05-30 |
Moriarty Kevin Joseph |
N-heterocyclic inhibitors of TNF-alpha expression
|
|
ES2452696T3
(es)
|
2000-01-24 |
2014-04-02 |
Genzyme Corporation |
Métodos para detectar inhibidores de JAK3
|
|
ATE269860T1
(de)
|
2000-01-31 |
2004-07-15 |
Pfizer Prod Inc |
Pyrimidinylcarboxamiden als inhibitoren der pde4 isoenzyme
|
|
EP1200422A2
(en)
|
2000-02-05 |
2002-05-02 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compositions useful as inhibitors of erk
|
|
JP4739632B2
(ja)
|
2000-02-05 |
2011-08-03 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ｅｒｋのインヒビターとして有用なピラゾール組成物
|
|
GB0004888D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
US6525051B2
(en)
|
2000-03-27 |
2003-02-25 |
Schering Aktiengesellschaft |
N-heterocyclic derivatives as NOS inhibitors
|
|
AR028261A1
(es)
|
2000-03-28 |
2003-04-30 |
Wyeth Corp |
Inhibidores triciclicos de la proteina quinasa
|
|
US6608048B2
(en)
|
2000-03-28 |
2003-08-19 |
Wyeth Holdings |
Tricyclic protein kinase inhibitors
|
|
JP5230050B2
(ja)
|
2000-05-08 |
2013-07-10 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
Ｈｉｖ複製阻害剤
|
|
CA2412560C
(en)
|
2000-06-26 |
2008-12-30 |
Pfizer Products Inc. |
Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents
|
|
GB0016877D0
(en)
|
2000-07-11 |
2000-08-30 |
Astrazeneca Ab |
Chemical compounds
|
|
AU2001229722A1
(en)
|
2000-11-29 |
2002-06-11 |
Parker Hughes Institute |
Inhibitors of thrombin induced platelet aggregation
|
|
US20020115173A1
(en)
|
2000-12-11 |
2002-08-22 |
Children's Medical Center Corporation |
Short peptides from the 'A-region' of protein kinases which selectively modulate protein kinase activity
|
|
CA2432114A1
(en)
|
2000-12-20 |
2002-07-18 |
Sugen, Inc. |
4-(hetero)aryl substituted indolinones
|
|
CZ304059B6
(cs)
|
2000-12-21 |
2013-09-11 |
Glaxo Group Limited |
Deriváty pyrimidinu a farmaceutický prostredek
|
|
FR2818642B1
(fr)
|
2000-12-26 |
2005-07-15 |
Hoechst Marion Roussel Inc |
Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilistion
|
|
US20040102455A1
(en)
|
2001-01-30 |
2004-05-27 |
Burns Christopher John |
Method of inhibiting kinases
|
|
AUPR279101A0
(en)
|
2001-01-30 |
2001-02-22 |
Cytopia Pty Ltd |
Protein kinase signalling
|
|
SE0101675D0
(sv)
|
2001-05-11 |
2001-05-11 |
Astrazeneca Ab |
Novel composition
|
|
MEP13408A
(en)
|
2001-05-29 |
2010-06-10 |
Bayer Schering Pharma Ag |
Cdk inhibiting pyrimidines, production thereof and their use as medicaments
|
|
US7301023B2
(en)
|
2001-05-31 |
2007-11-27 |
Pfizer Inc. |
Chiral salt resolution
|
|
WO2002102800A1
(en)
|
2001-06-15 |
2002-12-27 |
Vertex Pharmaceuticals Incorporated |
5-(2-aminopyrimidin-4-yl) benzisoxazoles as protein kinase inhibitors
|
|
US6433018B1
(en)
|
2001-08-31 |
2002-08-13 |
The Research Foundation Of State University Of New York |
Method for reducing hypertrophy and ischemia
|
|
WO2003020698A2
(en)
|
2001-09-06 |
2003-03-13 |
Prochon Biotech Ltd. |
Protein tyrosine kinase inhibitors
|
|
MXPA04002242A
(es)
|
2001-09-10 |
2005-03-07 |
Sugen Inc |
Derivados de 3-(4,5,6,7,-tetrahidroindol-2-ilmetiliden)-2-indolinona como inhibidores de cinasa.
|
|
WO2003030909A1
(en)
|
2001-09-25 |
2003-04-17 |
Bayer Pharmaceuticals Corporation |
2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
|
|
MXPA04003385A
(es)
|
2001-10-10 |
2005-04-11 |
Sugen Inc |
Derivados de 3-?4-substituido con heterociclilo)-pirrol-2-ilmetilidene?-2-indolinona como inhibidores de cinasa.
|
|
GT200200234A
(es)
|
2001-12-06 |
2003-06-27 |
|
Compuestos cristalinos novedosos
|
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
|
US6998391B2
(en)
|
2002-02-07 |
2006-02-14 |
Supergen.Inc. |
Method for treating diseases associated with abnormal kinase activity
|
|
CA2476281A1
(en)
|
2002-02-08 |
2003-08-14 |
Smithkline Beecham Corporation |
Pyrimidine compounds
|
|
JP2005524668A
(ja)
|
2002-03-01 |
2005-08-18 |
スミスクライン ビーチャム コーポレーション |
ジアミノピリミジン類及びそれらの血管新生阻害薬としての使用
|
|
GB0206215D0
(en)
|
2002-03-15 |
2002-05-01 |
Novartis Ag |
Organic compounds
|
|
AU2003231231A1
(en)
|
2002-05-06 |
2003-11-11 |
Bayer Pharmaceuticals Corporation |
Pyridinyl amino pyrimidine derivatives useful for treating hyper-proliferative disorders
|
|
RU2004135386A
(ru)
|
2002-05-06 |
2005-07-20 |
Вертекс Фармасьютикалз Инкорпорейтед (Us) |
Тиадиазолы или оксадиазолы и их применение в качестве ингибиторов протеинкиназы jak
|
|
RU2004138819A
(ru)
|
2002-05-30 |
2005-06-10 |
Вертекс Фармасьютикалз Инкорпорейтед (Us) |
Ингибиторы протеинкиназ jak и cdk2
|
|
WO2003106416A2
(en)
|
2002-06-17 |
2003-12-24 |
Smithkline Beecham Corporation |
Chemical process
|
|
US7449456B2
(en)
|
2002-06-28 |
2008-11-11 |
Astellas Pharma, Inc. |
Diaminopyrimidinecarboxamide derivative
|
|
RS51752B
(sr)
|
2002-07-29 |
2011-12-31 |
Rigel Pharmaceuticals |
Metode tretiranja i prevencije autoimunih oboljenja jedinjenjima 2,4-pirimidindiamina
|
|
AU2003262642B2
(en)
|
2002-08-14 |
2010-06-17 |
Vertex Pharmaceuticals Incorporated |
Protein kinase inhibitors and uses thereof
|
|
EP2172460A1
(en)
|
2002-11-01 |
2010-04-07 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of JAK and other protein kinases
|
|
EP1562938B1
(en)
|
2002-11-04 |
2007-08-29 |
Vertex Pharmaceuticals Incorporated |
Heteroaryl-pyrimidine derivatives as jak inhibitors
|
|
WO2004041810A1
(en)
|
2002-11-05 |
2004-05-21 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of jak and other protein kinases
|
|
AR042052A1
(es)
|
2002-11-15 |
2005-06-08 |
Vertex Pharma |
Diaminotriazoles utiles como inhibidores de proteinquinasas
|
|
PL377791A1
(pl)
|
2002-11-21 |
2006-02-20 |
Pfizer Products Inc. |
Pochodne 3-aminopiperydyny i sposoby ich wytwarzania
|
|
CA2507392A1
(en)
|
2002-11-26 |
2004-06-10 |
Pfizer Products Inc. |
Method of treatment of transplant rejection
|
|
WO2004058749A1
(en)
|
2002-12-18 |
2004-07-15 |
Vertex Pharmaceuticals Incorporated |
Benzisoxazole derivatives useful as inhibitors of protein kinases
|
|
DE602004021472D1
(en)
|
2003-02-20 |
2009-07-23 |
Smithkline Beecham Corp |
Pyrimiidinverbindungen
|
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
|
JP2006522124A
(ja)
|
2003-04-03 |
2006-09-28 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼのインヒビターとして有用な組成物
|
|
US7504396B2
(en)
|
2003-06-24 |
2009-03-17 |
Amgen Inc. |
Substituted heterocyclic compounds and methods of use
|
|
WO2005009957A1
(en)
|
2003-07-24 |
2005-02-03 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
RS53109B
(sr)
|
2003-07-30 |
2014-06-30 |
Rigel Pharmaceuticals Inc. |
Jedinjenja 2,4 pirimidindiamina za upotrebu u tretmanu ili prevenciji autoimunih bolesti
|
|
JP2007502266A
(ja)
|
2003-08-14 |
2007-02-08 |
ファイザー・インク |
Ｈｉｖ感染症を治療するためのピペラジン誘導体
|
|
BRPI0413616B8
(pt)
|
2003-08-15 |
2021-05-25 |
Irm Llc |
2,4-pirimidinadiaminas, seus usos, e composição farmacêutica
|
|
TWI339206B
(en)
|
2003-09-04 |
2011-03-21 |
Vertex Pharma |
Compositions useful as inhibitors of protein kinases
|
|
GB0321710D0
(en)
|
2003-09-16 |
2003-10-15 |
Novartis Ag |
Organic compounds
|
|
CN100412066C
(zh)
|
2003-09-30 |
2008-08-20 |
Irm责任有限公司 |
用作蛋白激酶抑制剂的化合物和组合物
|
|
DE602004010708T2
(de)
|
2003-10-03 |
2008-12-04 |
Pfizer Inc. |
Imidazopyridinsubstituierte tropanderivate mit ccr5-rezeptorantagonistischer wirkung zur behandlung von hiv und entzündungen
|
|
DE10349423A1
(de)
|
2003-10-16 |
2005-06-16 |
Schering Ag |
Sulfoximinsubstituierte Parimidine als CDK- und/oder VEGF-Inhibitoren, deren Herstellung und Verwendung als Arzneimittel
|
|
US20080207613A1
(en)
|
2004-01-12 |
2008-08-28 |
Cytopia Research Pty Ltd |
Selective Kinase Inhibitors
|
|
KR101216372B1
(ko)
|
2004-03-30 |
2013-01-04 |
버텍스 파마슈티칼스 인코포레이티드 |
Ｊａｋ 및 기타 단백질 키나제의 억제제로서 유용한 아자인돌
|
|
GB0407723D0
(en)
|
2004-04-05 |
2004-05-12 |
Novartis Ag |
Organic compounds
|
|
WO2005122294A1
(ja)
|
2004-06-14 |
2005-12-22 |
Nec Corporation |
フィルム外装電気デバイス
|
|
JP2008512429A
(ja)
|
2004-09-10 |
2008-04-24 |
ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ロフルミラストとｓｙｋインヒビターとの組合せ物並びにその使用方法
|
|
US20080027034A1
(en)
|
2004-09-10 |
2008-01-31 |
Shah Tushar P |
Ciclesonide and Syk Inhibitor Combination and Method of Use Thereof
|
|
CA2584295C
(en)
|
2004-11-24 |
2014-08-26 |
Rigel Pharmaceuticals, Inc. |
Spiro-2, 4-pyrimidinediamine compounds and their uses
|
|
KR101278397B1
(ko)
|
2005-01-19 |
2013-06-25 |
리겔 파마슈티칼스, 인크. |
2,4-피리미딘디아민 화합물의 전구약물 및 이의 용도
|
|
CA2604551A1
(en)
|
2005-05-03 |
2007-03-08 |
Rigel Pharmaceuticals, Inc. |
Jak kinase inhibitors and their uses
|
|
EA200800664A1
(ru)
|
2005-10-13 |
2009-02-27 |
Глаксо Груп Лимитед |
Производные пирролопиримидина в качестве ингибиторов syk
|
|
WO2007046112A1
(en)
|
2005-10-19 |
2007-04-26 |
Suven Life Sciences Inc. |
Arylthioether tryptamine derivatives as functional 5-ht6 ligands
|
|
WO2007070872A1
(en)
|
2005-12-15 |
2007-06-21 |
Rigel Pharmaceuticals, Inc. |
Kinase inhibitors and their uses
|
|
NL2000323C2
(nl)
|
2005-12-20 |
2007-11-20 |
Pfizer Ltd |
Pyrimidine-derivaten.
|
|
GB0526246D0
(en)
|
2005-12-22 |
2006-02-01 |
Novartis Ag |
Organic compounds
|
|
AU2007233737B2
(en)
|
2006-03-30 |
2012-11-29 |
Janssen Sciences Ireland Uc |
HIV inhibiting 5-amido substituted pyrimidines
|
|
JP2009542604A
(ja)
|
2006-07-06 |
2009-12-03 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
４−ヘテロシクロアルキルピリミジン、それらの調製方法及び医薬としての使用
|
|
RU2009105826A
(ru)
|
2006-07-21 |
2010-08-27 |
Новартис АГ (CH) |
2,4-ди(ариламино)питимидин-5-карбоксамидные соединения в качестве ингибиторов jak-киназ
|
|
WO2008024963A1
(en)
|
2006-08-24 |
2008-02-28 |
Serenex, Inc. |
Benzene, pyridine, and pyridazine derivatives
|
|
MX2009004426A
(es)
|
2006-10-23 |
2009-08-12 |
Cephalon Inc |
Derivados biciclicos fusionados de 2,4-diaminopirimidina como inhibidores alk y c-met.
|
|
US20080139531A1
(en)
|
2006-12-04 |
2008-06-12 |
Alcon Manufacturing Ltd. |
Use of connective tissue mast cell stabilizers to facilitate ocular surface re-epithelization and wound repair
|
|
EP2114902B1
(en)
|
2006-12-29 |
2014-09-17 |
Janssen R&D Ireland |
Hiv inhibiting 5,6-substituted pyrimidines
|
|
PE20090996A1
(es)
|
2007-04-02 |
2009-07-15 |
Palau Pharma Sa |
Derivados de pirrolopirimidina como inhibidores de cinasa jak3
|
|
WO2008135786A1
(en)
|
2007-05-04 |
2008-11-13 |
Astrazeneca Ab |
Amino-thiazolyl- pyrimidine derivatives and their use for the treatment of cancer
|
|
EP2157090A4
(en)
|
2007-06-21 |
2011-09-07 |
Taisho Pharmaceutical Co Ltd |
PYRAZINAMIDE COMPOUND
|
|
JP2010538004A
(ja)
|
2007-08-28 |
2010-12-09 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
キナーゼ阻害剤としての２−ビフェニルアミノ−４−アミノピリミジン誘導体
|
|
JP5496898B2
(ja)
|
2007-10-12 |
2014-05-21 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
タンパク質リフォールディングのための方法および剤
|
|
US20090270418A1
(en)
|
2008-01-09 |
2009-10-29 |
Marianne Sloss |
Pyrazole pyrazine amine compounds as kinase inhibitors, compositions thereof and methods of treatment therewith
|
|
WO2009097541A1
(en)
|
2008-02-01 |
2009-08-06 |
Rich Products Corporation |
Foam compositions
|
|
JP5802127B2
(ja)
*
|
2008-04-16 |
2015-10-28 |
ポートラ ファーマシューティカルズ， インコーポレイテッド |
Ｓｙｋ又はｊａｋキナーゼ阻害剤としての２，６−ジアミノ−ピリミジン−５−イル−カルボキサミド類
|
|
AU2009244897B2
(en)
|
2008-04-16 |
2014-11-13 |
Alexion Pharmaceuticals, Inc. |
2, 6-diamino- pyrimidin- 5-yl-carboxamides as syk or JAK kinases inhibitors
|
|
CA2723205C
(en)
|
2008-04-16 |
2017-03-14 |
Portola Pharmaceuticals, Inc. |
2,6-diamino-pyrimidin-5-yl-carboxamides as syk or jak kinase inhibitors
|
|
US8138339B2
(en)
|
2008-04-16 |
2012-03-20 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
|
WO2009131687A2
(en)
|
2008-04-22 |
2009-10-29 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
|
MX2011002825A
(es)
|
2008-09-18 |
2011-04-05 |
Astellas Pharma Inc |
Compuestos heterociclicos de carboxamida.
|
|
EP2361902A4
(en)
|
2008-11-21 |
2012-04-25 |
Astellas Pharma Inc |
4,6-DIAMINONICOTINSÄUREAMIDVERBINDUNG
|
|
JP5542692B2
(ja)
|
2008-11-28 |
2014-07-09 |
興和株式会社 |
ピリジン−３−カルボキシアミド誘導体
|
|
AU2010219097A1
(en)
|
2009-01-13 |
2011-08-04 |
Glaxo Group Limited |
Pyrimidinecarboxamide derivatives as inhibitors of SYK kinase
|
|
TW201040162A
(en)
|
2009-05-06 |
2010-11-16 |
Portola Pharm Inc |
Inhibitors of JAK
|
|
SI3009428T1
(en)
*
|
2009-05-08 |
2018-04-30 |
Astellas Pharma Inc. |
DIAMINO HETEROCYCLIC CARBOSAMIDE COMPOUNDS
|
|
US20130244963A1
(en)
|
2010-09-30 |
2013-09-19 |
Portola Pharmaceuticals, Inc. |
Combination therapy with 4-(3-(2h-1,2,3-triazol-2-yl)phenylamino)-2-((1r,2s)-2-aminocyclohexylamino)pyrimidine-5-carboxamide
|
|
US20130252917A1
(en)
|
2010-09-30 |
2013-09-26 |
Portola Pharmaceuticals, Inc. |
Combination therapy of 4-(3-(2h-1,2,3-triazo-2-yl)phenylamino)-2-((1r,2s)-2-aminocyclohexylamino)pyrimidine-5-carboxamide and fludarabine
|
|
JP2014005206A
(ja)
|
2010-10-22 |
2014-01-16 |
Astellas Pharma Inc |
アリールアミノヘテロ環カルボキサミド化合物
|
|
EP2635557A2
(en)
|
2010-11-01 |
2013-09-11 |
Portola Pharmaceuticals, Inc. |
Nicotinamides as jak kinase modulators
|
|
WO2012061415A1
(en)
|
2010-11-01 |
2012-05-10 |
Portola Pharmaceuticals, Inc. |
Oxypyrimidines as syk modulators
|
|
US8877760B2
(en)
|
2011-11-23 |
2014-11-04 |
Portola Pharmaceuticals, Inc. |
Substituted pyrazine-2-carboxamide kinase inhibitors
|
|
EP2782580A4
(en)
|
2011-11-23 |
2015-10-07 |
Portola Pharm Inc |
SELECTIVE INHIBITORS OF KINASES
|